With beginning of 2021 Glycotope will offer its Contract Development Organization (CDO) and Clinical Lab services under the brand name FyoniBio®, the service branch of Glycotope.
With 20 years of history in biopharma development FyoniBio® is in a perfect position to bring value to customers in many preclinical areas as well as clinical lab service.
In short, FyoniBio®offerings include:
- Cell line development in CHO and GEX® cells
- USP and DSP process development
- MS based protein and glycan analytics
- Bioassay development
- Clinical immunomonitoring